Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders?

Psychiatry Research

Volumn 36, Issue 2, 1991, Pages 141-155

  Elia, Josephine ^a   Borcherding, Breck G ^b   Rapoport, Judith L ^a   Keysor, Cynthia S ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b Frederick Medical Center   (United States)

^c Judith L Rapoport MD is Chief Child Psychiatry Branch National Institute of Mental Health Bethesda MD USA ^*  (United States)

Author keywords

dextroamphetamine; hyperactivity; methylphenidate; Stimulants

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; HUMAN; HYPERACTIVITY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COMPARATIVE STUDY; DAY CARE; DEXTROAMPHETAMINE; DOUBLE-BLIND METHOD; HUMAN; MALE; METHYLPHENIDATE; PLACEBOS; RESEARCH DESIGN;

EID: 0026060071     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(91)90126-A     Document Type: Article

References (36)

1. Measurement of attention distractibility in LD children
2. Methylphenidate vs. dextroamphetamine vs. caffeine in minimal brain dysfunction
3. The making of a myth
4. Tables on the Bonferroni t statistic
5. A review of stimulant drug research with hyperactive children
6. Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children
7. Motor/vocal tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability?
8. Benzedrine and dexedrine in the treatment of children's behavior disorders
9. An ambulatory activity monitor with solid-state memory
10. The effect of stimulant drugs on human figure drawings in dhildren with minimal brain dysfunction
11. Psychological effects of stimulant drugs in children with minimal brain dysfunction
12. Psychological assessment of children with minimal brain dysfunction
13. Rating scales for use in drug studies with children
14. Revised Physical and Neurological Examination for Subtle Signs
15. Children's Psychiatric Rating Scale
16. Are behavioral and psychometric changes related in methylphenidate-treated, hyperactive children?
17. Normative data on the Revised Conners Parent and Teacher Rating Scales
18. Subject's Treatment Emergent Symptom Scale
19. Differentiating psychiatrically disturbed children on the basis of a structural interview
20. Caffeine versus methylphenidate and d-amphetamine in minimal brain dysfunction: A double-blind comparison
21. Patient activity monitor (PAM) software for the Macintosh: A system for collecting activity data
22. Drugs in management of hyperkinetic and perceptually handicapped children
23. Treatment of “minimal brain dysfunction” syndromes
24. Clinical Global Impression Scale (CGI)
25. Do single measures predict ADD children's comprehensive response to psychostimulants?
26. Behavioral assessment of psychostimulant effects on ADD children in a summer day treatment program
27. Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys
28. A Children's Global Assessment Scale (CGAS)
29. Methylphenidate in hyperkinetic children: Differences in dose effect on learning and social behavior
30. Measures of cognitive functioning appropriate for use in pediatric psychopharmacology research studies
31. Intraindividual comparison of twenty-one day application of amphetaminil and methylphenidate in hyperkinetic children
32. Is there dose-dependent tolerance associated with chronic methylphenidate therapy in hyperactive children: Oral dose and plasma concentrations
33. Dextroamphetamine and methylphenidate in the treatment of hyperactive/aggressive children
34. Treatment of hyperactive children with monoamine oxidase inhibitors